QuestCap EV/EBIT
Mi az QuestCap EV/EBIT?
A EV/EBIT az QuestCap Inc. - 0.28
Mi a EV/EBIT meghatározása?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT a Finance szektor a OTC-on cégekben a QuestCap -hoz képest
Mit csinál QuestCap?
Medivolve Inc. is a principal investment firm. It is a social-impact investment focused company Investing resources, funds and bandwidth for the betterment of the human condition through medical sciences, climate change and technology. The firm was formerly known as Continent Resources Inc. and changed its name to Copper One Inc. in October 2009. Copper One Inc. was incorporated in 2005 and is headquartered in Toronto, Canada.
ev/ebit -hoz hasonló cégek QuestCap
- Noble plc nak EV/EBIT 0.26 van
- Enwell plc nak EV/EBIT 0.26 van
- Homology Medicines Inc nak EV/EBIT 0.26 van
- Immunic nak EV/EBIT 0.27 van
- Sage Therapeutics Inc nak EV/EBIT 0.27 van
- Novacyt S.A nak EV/EBIT 0.27 van
- QuestCap nak EV/EBIT 0.28 van
- Oncternal Therapeutics nak EV/EBIT 0.28 van
- Sulliden Mining Capital nak EV/EBIT 0.29 van
- J4 Ventures nak EV/EBIT 0.29 van
- Sulliden Mining Capital nak EV/EBIT 0.30 van
- Bio-Path Inc nak EV/EBIT 0.31 van
- Freeline Therapeutics plc nak EV/EBIT 0.31 van